|
|
Volumn 8, Issue 4, 2007, Pages 286-
|
|
Dasatinib is effective in imatinib-resistant CML.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DASATINIB;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ARTICLE;
CHRONIC MYELOID LEUKEMIA;
DRUG APPROVAL;
DRUG RESISTANCE;
HUMAN;
LEGAL ASPECT;
TREATMENT OUTCOME;
UNITED KINGDOM;
DRUG APPROVAL;
DRUG RESISTANCE, NEOPLASM;
GREAT BRITAIN;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
THIAZOLES;
TREATMENT OUTCOME;
|
|
EID: 34247570352
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(07)70088-8 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
